Register and DNA Bank of Adult Extra-hospital Sudden Death (Protocol FASTER)

NCT01321918 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2011-03-24

No results posted yet for this study

Summary

The main objective of this study is the formation of a DNA bank to realise a case-control genetic study designed to identify sequence variations in DNA that predispose to sudden cardiac death in adults.

The secondary objective of this study is the creation of a register for epidemiological surveillance of adult extra-hospital sudden death.

Conditions

  • Extra-hospital Sudden Death

Interventions

OTHER

Case Controls

A blood sample of 10 ml (2 x 5 ml) on two EDTA tubes will be realised on a route of vascular development place in the context of medical practice.Clinical data will be indicated in the CRF and the computerized database. In the event an eligible patient has not been included during his support by an emergency ambulance service but, after successful resuscitation, he has been hospitalised in a cardiology department, its inclusion may be realised during the hospitalization by a physician investigator of the study. A blood sample of 10 ml of 2 EDTA tubes will be realised on a route of vascular development in the context of routine care.

OTHER

Control subjects

A blood sample of 10 ml (2 x 5 ml) on two EDTA tubes will be realised and clinical data will be indicated in the CRF and the computerized database.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Vincent PROBST, Profesor · Nantes University Hospital

  • Jean-Luc CHASSEVENT, Doctor · University Hospital, Angers

  • Nicolas HOURDIN, Doctor · CH de Châteaubriant

  • Yves-Marie PLUCHON, Doctor · CH de la Roche-sur-Yon

  • Christophe SAVIO, Doctor · CH du Mans

  • Jean-Pierre AUFFRAY, Profesor · CHU de Marseille

  • Christian HAMON, Doctor · CH de Saint-Brieuc

  • Christophe BERRANGER, Profesor · CH de Saint-Nazaire

  • Jean-Louis DUCASSE, Doctor · University Hospital, Toulouse

  • BOULANGER, Doctor · CH de Vannes

Study Design

Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321918 on ClinicalTrials.gov